May 28, 2020

33: Goal: One Billion Doses by the End of 2021, Goal: One Billion Doses by the End of 2021, with Alex Gorsky, Chairman and CEO, Johnson & Johnson--COVID-19 Series

35 minutes

Please note: The number of COVID-19 cases and the situation referenced in this episode were based on reported data at the time of the interview and are subject to change.

Transcription

Alex Gorsky 0:03
As we announced in late March, our goal is to be able to do this in a safe and effective way and have more than a billion vaccines by the end of 2021. We're working with regulators in the United States and around the world. We're partnering with other companies, particularly manufacturing facilities to be able to scale up so that we can produce here in the United States, but also around the globe. And that we would be doing all of this on a not-for-profit basis.

Gary Bisbee 0:29
That was Alex Gorsky, Chairman and CEO, Johnson and Johnson, on J&J's goal to produce 1 billion doses of coronavirus vaccine by the end of 2021. And to do so on a not for profit basis. I'm Gary Bisbee. And this is Fireside Chat. The most important next step in the battle against coronavirus is the availability of a vaccine. Alex discusses the prospects in progress as of May 20, 2020. The day this conversation was recorded.

Alex Gorsky 0:57
For making good progress there's still a lot of work that needs to be done. Much more testing needs to be concluded. But every piece of data and new insights that we gather, I think, are giving us greater confidence that this is certainly something that is possible, and that we're going to do everything we can to make it happen.

Gary Bisbee 1:14
The vaccine update is all-important. And in addition, we went deep with Alex on a wide range of topics, including the development of medicines to treat COVID, lessons learned from J&J's global and resilient supply chain, the most important characteristics of a leader in a crisis, key questions the board should ask in a crisis like COVID-19, the resources and support J&J have devoted to frontline workers and the value of J&J's diversified business model. I'm delighted to welcome Alex Gorsky to the microphone.

Good afternoon, Alex, and welcome.

Alex Gorsky 1:53
Hey, Gary, thank you very much for having me.

Gary Bisbee 1:54
Well, we're pleased to have you at this microphone. Let's lead off w

Welcome to the Health System CXO Podcast, sponsored by The Health Management Academy, featuring content designed for Health System Nurse Executives, Health Equity Officers and Strategy Executives provided by our company SME's - Anne Herleth, Jasmaine McClain, Ph.D. and Jackie Kimmell.

Subscribe today and receive the latest insights from the country's leading Health System CXO experts regularly, helping you remain current and guide your health system strategy with thought leadership and success.

The Health System CXO Podcast activates health system leaders towards outcomes and scalable solutions you can implement now.

About The Health Management Academy:
Since 1998, The Health Management Academy has cultivated the premier community of healthcare's most influential changemakers from the top U.S. health systems and innovative industry partners. We power more than 2,000 health system senior executives and 200 industry organizations through exceptional peer groups, original market insights, world-class leadership development programs and novel member alliances. Our industry-leading programs and solutions enable members to facilitate meaningful relationships, navigate strategic transformation and address critical industry issues. To learn more, visit hmacademy.com and follow The Health Management Academy on ...

...more

View all episodes

By The Health Management Academy

4.9

4545 ratings